Lyell Immunopharma Inc
Closed
13.3 -3.97
Overview
Share price change
24h
Min
13.11
Max
13.57
Income | 117M -24M |
|---|---|
Sales | -4K 2K |
EPS | -1.1 |
Profit margin | -1,207,650 |
Employees | 161 |
EBITDA | 38M -22M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +181.53% upside |
Next Earnings | 10 Aug 2026 |
|---|
Market Cap | -149M 334M |
|---|---|
Previous open | 17.27 |
Previous close | 13.3 |
Lyell Immunopharma Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Lyell Immunopharma Inc Forecast
Price Target
By TipRanks
181.53% upside
12 Months Forecast
Average 37.5 USD 181.53%
High 49 USD
Low 12 USD
Based on 4 Wall Street analysts offering 12 month price targets forLyell Immunopharma Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$